drugset / Trial / NCT00756938

Study of Losartan in Pediatric Patients With Hypertension (MK-0954-337)

NCT00756938

Phase 3 Completed 101 enrolled Organon and Co
RandomizedParallel-groupOpen-labelTreatment

Summary

This study will explore the dose-response of losartan as well as the safety and tolerability in children from 6 months to 6 years of age.

Timeline

Start
2009-03-01
Primary completion
2012-08-14
Completion
2012-08-14

Drugs

EvaluationDrugModalityDoseRoute
Subject Losartan Other / unclassified 0.1 mg/kg Oral
Subject Losartan Other / unclassified 0.3 mg/kg Oral
Subject Losartan Other / unclassified 0.7 mg/kg Oral

Indications